{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:28:58Z","timestamp":1780046938676,"version":"3.53.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.radonc.2017.02.009","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T18:30:34Z","timestamp":1489170634000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Acute toxicity and surgical complications after preoperative (chemo)radiation therapy for rectal cancer in patients with inflammatory bowel disease"],"prefix":"10.1016","volume":"123","author":[{"given":"Steven L.","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J.","family":"van Rooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus M.J.","family":"B\u00f6kkerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidde J.W.","family":"Braam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauranne A.A.P.","family":"Derikx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrie A.M.","family":"Marijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris D.","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.W.","family":"de Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2017.02.009_b0005","first-page":"390","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract"},{"key":"10.1016\/j.radonc.2017.02.009_b0010","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.radonc.2017.02.009_b0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.12651","article-title":"Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis","volume":"39","author":"Castano-Milla","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.radonc.2017.02.009_b0020","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/MIB.0000000000000173","article-title":"Inflammatory bowel disease cause-specific mortality: a primer for clinicians","volume":"20","author":"Kassam","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0025","doi-asserted-by":"crossref","first-page":"V10","DOI":"10.1136\/gut.51.suppl_5.v10","article-title":"Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease","volume":"51","author":"Eaden","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2017.02.009_b0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0035","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.02.009_b0040","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ibd.20766","article-title":"Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon","volume":"15","author":"Ullman","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jso.23465","article-title":"A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome","volume":"109","author":"Hrabe","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0050","doi-asserted-by":"crossref","first-page":"1.e1","DOI":"10.1016\/j.ejca.2013.06.048","article-title":"EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum","volume":"50","author":"van de Velde","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2017.02.009_b0055","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2017.02.009_b0060","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijrobp.2010.03.008","article-title":"Evaluation of biologic effective dose and schedule of fractionation for preoperative radiotherapy for rectal cancer: meta-analyses and meta-regression","volume":"80","author":"Viani","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.02.009_b0065","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clon.2015.05.001","article-title":"Acute and late bowel toxicity in radiotherapy patients with inflammatory bowel disease: a systematic review","volume":"27","author":"Tromp","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0070","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0360-3016(99)00091-7","article-title":"Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy","volume":"44","author":"Green","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.02.009_b0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00384-014-2103-8","article-title":"Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits","volume":"30","author":"Chang","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0080","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0085","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1200\/JCO.2002.20.3.817","article-title":"Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial","volume":"20","author":"Marijnen","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0090","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1365-2168.2002.02136.x","article-title":"Retrospective study of acute toxicity following short-course preoperative radiotherapy","volume":"89","author":"Hartley","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2017.02.009_b0095","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3\u20134 rectal cancers: results of FFCD 9203","volume":"24","author":"Gerard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/bjs.6914","article-title":"Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer","volume":"97","author":"Pettersson","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2017.02.009_b0105","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events v 4.0 (CTCAE); 2009."},{"key":"10.1016\/j.radonc.2017.02.009_b0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2017.02.009_b0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0120","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9","article-title":"TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer","volume":"80","author":"Sobin","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.02.009_b0125","series-title":"WHO classification of tumours of the digestive system","author":"Bosman","year":"2010"},{"key":"10.1016\/j.radonc.2017.02.009_b0130","first-page":"470","article-title":"Radiation enteropathy\u2013pathogenesis, treatment and prevention","volume":"11","author":"Hauer-Jensen","year":"2014","journal-title":"Nat Rev"},{"key":"10.1016\/j.radonc.2017.02.009_b0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2015.04.016","article-title":"Radiation triggering immune response and inflammation","volume":"368","author":"Hekim","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.radonc.2017.02.009_b0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.v19.i2.185","article-title":"Gastrointestinal radiation injury: symptoms, risk factors and mechanisms","volume":"19","author":"Shadad","year":"2013","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.radonc.2017.02.009_b0145","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2017.02.009_b0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00384-009-0823-y","article-title":"Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity","volume":"25","author":"Kube","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF02234323","article-title":"Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity","volume":"44","author":"Read","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.radonc.2017.02.009_b0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/bjs.7315","article-title":"Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer","volume":"98","author":"Swellengrebel","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2017.02.009_b0165","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1200\/JCO.2010.34.4911","article-title":"Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial","volume":"29","author":"Aschele","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0170","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","article-title":"Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2","volume":"28","author":"Gerard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0175","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial","volume":"13","author":"Rodel","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0180","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","article-title":"Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer","volume":"26","author":"Braendengen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0185","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2017.02.009_b0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0360-3016(01)01629-7","article-title":"Acute and late radiotherapy toxicity in patients with inflammatory bowel disease","volume":"51","author":"Song","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.02.009_b0195","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0360-3016(99)00374-0","article-title":"Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms","volume":"46","author":"Willett","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.02.009_b0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1463-1318.2005.00796.x","article-title":"Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs chemoradiation","volume":"7","author":"Bujko","year":"2005","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0205","first-page":"2269","article-title":"The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group","volume":"75","author":"Cedermark","year":"1995"},{"key":"10.1016\/j.radonc.2017.02.009_b0210","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1463-1318.2006.01029.x","article-title":"Short course preoperative radiotherapy is the single most important risk factor for perineal wound complications after abdominoperineal excision of the rectum","volume":"8","author":"Chadwick","year":"2006","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-4-67","article-title":"Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy\u2013long-term results","volume":"4","author":"Guckenberger","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.02.009_b0220","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/codi.12193","article-title":"Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer","volume":"15","author":"Hesselager","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00384-006-0195-5","article-title":"Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery","volume":"22","author":"Veenhof","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0230","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.bjc.6602485","article-title":"Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)","volume":"92","author":"Widder","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2017.02.009_b0235","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.surg.2013.10.020","article-title":"Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision?","volume":"155","author":"Maggiori","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.radonc.2017.02.009_b0240","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.amjsurg.2012.11.018","article-title":"Corticosteroids and wound healing: clinical considerations in the perioperative period","volume":"206","author":"Wang","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.radonc.2017.02.009_b0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/codi.12490","article-title":"Treatment with corticosteroids and the risk of anastomotic leakage following lower gastrointestinal surgery: a literature survey","volume":"16","author":"Eriksen","year":"2014","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.radonc.2017.02.009_b0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1748-717X-5-17","article-title":"Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications","volume":"5","author":"Arbea","year":"2010","journal-title":"Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017300750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017300750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T17:25:04Z","timestamp":1535995504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814017300750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0167814017300750"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2017.02.009","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute toxicity and surgical complications after preoperative (chemo)radiation therapy for rectal cancer in patients with inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2017.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}